Not medical advice. We don't sell peptides. Votes and comments are community opinion, not clinical guidance.
💊

b/glp1

GLP-1 · 0 members · 12 posts

The whole GLP-1 class: approved drugs, compounding, and online knockoffs.

Not medical advice

Rules
Be precise. Show receipts. No vendor links. Be kind.

b/GLP-1 meters claims — it does not sell products or issue medical or financial advice.
💊b/glp1u/tmb_bot · Imported from ClinicalTrials.gov

Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With Obesity

RECRUITING · Yuzuncu Yil University Imported from ClinicalTrials.gov. This was filed by the system importer, not a fake user. Possible receipts (auto-attached from public APIs — verify before trusting): - ClinicalTrials.gov: PRE-Pregnancy Weight Loss And the Reducing Effect on CHILDhood Overweight - Aarhus — https://clinicaltrials.gov/study/NCT05798494

What the receipts say: Receipts · Imported from ClinicalTrials.gov — not a verdict.

LEGITSKETCHYTOTAL CAP
UNRATED
💊b/glp1u/tmb_bot · Imported from ClinicalTrials.gov

The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes

RECRUITING · Imperial College London Imported from ClinicalTrials.gov. This was filed by the system importer, not a fake user. Possible receipts (auto-attached from public APIs — verify before trusting): - ClinicalTrials.gov: The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes — https://clinicaltrials.gov/study/NCT06318442

What the receipts say: Receipts · Imported from ClinicalTrials.gov — not a verdict.

LEGITSKETCHYTOTAL CAP
UNRATED
💊b/glp1u/tmb_bot · Imported from PubMed

GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes with CKD stages 2-4: a target trial emulation

Published in Diabetol Metab Syndr. Imported from PubMed. This was filed by the system importer, not a fake user. Possible receipts (auto-attached from public APIs — verify before trusting): - PubMed: Distinct temporal neuropsychiatric outcomes associated with GLP-1 receptor agonists versus SGLT2 inhibitors after acute kidney disease in type 2 diabetes — https://pubmed.ncbi.nlm.nih.gov/43010906/ - PubMed: GLP-1 receptor agonists for people with type 2 diabetes and peripheral artery disease: reducing uncertainty in clinical practice — https://pubmed.ncbi.nlm.nih.gov/43007383/ - ClinicalTrials.gov: iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases — https://clinicaltrials.gov/study/NCT03549754

What the receipts say: Receipts · Imported from PubMed — not a verdict.

LEGITSKETCHYTOTAL CAP
UNRATED
💊b/glp1u/tmb_bot · Imported from PubMed

GLP-1 based therapy of obesity and type 2 diabetes

Published in Diabetol Int. Imported from PubMed. This was filed by the system importer, not a fake user. Possible receipts (auto-attached from public APIs — verify before trusting): - ClinicalTrials.gov: A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes — https://clinicaltrials.gov/study/NCT05433584

What the receipts say: Receipts · Imported from PubMed — not a verdict.

LEGITSKETCHYTOTAL CAP
UNRATED
💊b/glp1u/tmb_bot · Imported from PubMed

GLP-1-based Therapies in MASH: From Metabolic Benefits to an Improvement in Liver Fibrosis

Published in Intern Med. Imported from PubMed. This was filed by the system importer, not a fake user. Possible receipts (auto-attached from public APIs — verify before trusting): - PubMed: GLP-1-based Therapies in MASH: From Metabolic Benefits to an Improvement in Liver Fibrosis — https://pubmed.ncbi.nlm.nih.gov/43014742/ - PubMed: Will GLP-1-based therapies reshape the epidemiology of MASLD? An emerging public health perspective — https://pubmed.ncbi.nlm.nih.gov/42996399/

What the receipts say: Receipts · Imported from PubMed — not a verdict.

LEGITSKETCHYTOTAL CAP
UNRATED
💊b/glp1u/tmb_bot · Starter claim

GLP-1 means you can ignore diet, training, and side effects

Starter claim — filed by the official system account u/tmb_bot to open discussion in this community. Votes start at zero. The Bro-Meter is driven only by user votes. NIH diabetes and weight-management pages, and FDA product information, still include lifestyle and safety information. Total-replacement claims go beyond those sources. This is a discussion of a public claim, not medical advice, and not a sourcing or dosing guide. Sources: - https://www.niddk.nih.gov/health-information/diabetes - https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss

What the receipts say: Receipts Official sources never set the Bro-Meter.

LEGITSKETCHYTOTAL CAP
UNRATED
💊b/glp1u/tmb_bot · Starter claim

All the GLP-1 you can buy online is the same as the brand pens

Starter claim — filed by the official system account u/tmb_bot to open discussion in this community. Votes start at zero. The Bro-Meter is driven only by user votes. FDA has issued specific information about approved semaglutide products and about compounded versions. Online listings are not automatically the approved drugs. This is a discussion of a public claim, not medical advice, and not a sourcing or dosing guide. Sources: - https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss - https://www.fda.gov/drugs/human-drug-compounding/understanding-risks-compounded-drugs

What the receipts say: Receipts Official sources never set the Bro-Meter.

LEGITSKETCHYTOTAL CAP
UNRATED
💊b/glp1u/tmb_bot · Starter claim

TikTok side-effect stories are the real risk profile

Starter claim — filed by the official system account u/tmb_bot to open discussion in this community. Votes start at zero. The Bro-Meter is driven only by user votes. Labeled risks come from official product information, not from viral compilations. FDA's semaglutide safety pages are the primary source. This is a discussion of a public claim, not medical advice, and not a sourcing or dosing guide. Sources: - https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss - https://consumer.ftc.gov/health

What the receipts say: Receipts Official sources never set the Bro-Meter.

LEGITSKETCHYTOTAL CAP
UNRATED
💊b/glp1u/tmb_bot · Starter claim

During a shortage, any compounded version is just as good

Starter claim — filed by the official system account u/tmb_bot to open discussion in this community. Votes start at zero. The Bro-Meter is driven only by user votes. Shortage and compounding policy are specific and have been addressed by FDA in writing. Equivalence is not automatic. This is a discussion of a public claim, not medical advice, and not a sourcing or dosing guide. Sources: - https://www.fda.gov/drugs/human-drug-compounding/understanding-risks-compounded-drugs - https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss

What the receipts say: Receipts Official sources never set the Bro-Meter.

LEGITSKETCHYTOTAL CAP
UNRATED